Indoramin is a member of tryptamines. Indoramin is a discontinued piperidine antiadrenergic drug with the trade names Baratol and Doralese. It is a selective alpha-1 adrenergic antagonist with no reflex tachycardia and direct myocardial depression action. INDORAMIN is a small molecule drug with a maximum clinical trial phase of IV and is indicated in hypertension. It is grouped under the following drug class(es): Alpha-1 Blockers. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Baratol and Indoraminum. Its PubChem CID is 33625.
Indoramin
| CAS No | 26844-12-2 |
|---|---|
| Molecular Formula | C22H25N3O |
| Molecular Weight | 347.5 g/mol |
| Synonyms | N-[1-[2-(1H-indol-3-yl)ethyl]piperidin-4-yl]benzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Indoramin is a member of tryptamines. Indoramin is a discontinued piperidine antiadrenergic drug with the trade names Baratol and Doralese. It is a selective alpha-1 adrenergic antagonist with no reflex tachycardia and direct myocardial depression action.
The listed CAS number is 26844-12-2.
The listed molecular formula is C22H25N3O.
The listed molecular weight is 347.5 g/mol.
N-[1-[2-(1H-indol-3-yl)ethyl]piperidin-4-yl]benzamide.
The source lists Baratol and Indoraminum.